TABLE 3.

Clinical outcomes of the study participants¹

	Standard	Experimental
Mortality [n (%)]	2 (15)	1 (8)
Engraftment time (d)	24 ± 52	24 ± 6
Patients with confirmed infections during follow-up period [n (%)]	6 (46)	4 (31)
No. of infections	0.6 ± 0.9	1.1 ± 2.3
Patients with GVHD during follow-up period [n (%)]	4 (31)	1 (8)
Patients with veno-occlusive disease [n (%)]	1 (8)	1 (8)
Length of hospital stay (d)	42 ± 12	39 ± 10

¹Mean values of each continuous variable were compared between trial arms by Student's t test, corroborated by Wilcoxon's 2-sample test in cases of skewed distribution. The distribution of each binary variable was compared by Fisher's exact test. All differences were nonsignificant, P > 0.30. GVHD, graft-versus-host disease.

²Mean ± SD (all such values).